Assignee
DNATRIX INC
US·4 granted patents·11 pending applications·12 citations·filing 2014–2024
Top patents by PatentIndex Score
15 records- 0190US10016470B2Oncolytic adenoviruses for cancer treatmentDNATRIX INC·Filed 2016·Granted Jul 10, 2018·11 cites·12 claims
- 0282US2025171745A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2024·Application pending·0 cites
- 0373US11090344B2Adenovirus and immunomodulator combination therapyDNATRIX INC·Filed 2017·Granted Aug 17, 2021·1 cites·14 claims
- 0468US2021301264A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2021·Application pending·0 cites
- 0567US11065285B2Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2020·Granted Jul 20, 2021·0 cites·14 claims
- 0662US2019183946A1Oncolytic adenoviruses for cancer treatmentDNATRIX INC·Filed 2018·Application pending·0 cites
- 0761US2015071881A1Oncolytic Adenoviruses for Cancer TreatmentDNATRIX INC·Filed 2014·Application pending·0 cites
- 0860US2021213079A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2021·Application pending·0 cites
- 0958US2016289645A1Adenovirus Expressing Immune Cell Stimulatory Receptor Agonist(s)DNATRIX INC·Filed 2014·Application pending·0 cites
- 1056US2019093085A1Adenovirus expressing immune cell stimulatory receptor agonist(s)DNATRIX INC·Filed 2018·Application pending·0 cites
- 1154US2024216492A1Use of oncolytic adenovirus for the treatment of pediatric brain cancerDNATRIX INC·Filed 2022·Application pending·0 cites
- 1252US2019269744A1Biomarkers and combination therapies using oncolytic virus and immunomodulationDNATRIX INC·Filed 2019·Application pending·0 cites
- 1350US11110137B2Combination therapy for treatment of brain cancersDNATRIX INC·Filed 2020·Granted Sep 7, 2021·0 cites·31 claims
- 1447US2016143967A1Treatment of brain cancer with oncolytic adenovirusDNATRIX INC·Filed 2014·Application pending·0 cites
- 1540US2019275092A1Combination therapy for treatment of brain cancersDNATRIX INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →